Benefits of newer vaccines lauded: multiresistant pneumococcal strains emerging.
Kuehn
Bridget M
BM
D000293:Adolescent; D000328:Adult; D052685:Alphapapillomavirus / Q000145:classification*; D002648:Child; D002675:Child, Preschool; D024901:Drug Resistance, Multiple, Bacterial; D005260:Female; D000069443:Heptavalent Pneumococcal Conjugate Vaccine; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D006801:Humans; D007223:Infant; D008297:Male; D022401:Meningococcal Vaccines; D010033:Otitis Media / Q000382:microbiology; D030361:Papillomavirus Infections / Q000517:prevention & control; D053918:Papillomavirus Vaccines; D011008:Pneumococcal Infections / Q000517:prevention & control; D022242:Pneumococcal Vaccines; D012703:Serotyping; D013296:Streptococcus pneumoniae / Q000145:classification* / Q000187:drug effects
D000069443:Heptavalent Pneumococcal Conjugate Vaccine; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D022401:Meningococcal Vaccines; D053918:Papillomavirus Vaccines; D022242:Pneumococcal Vaccines